Health Evidence hosted a 60 minute webinar examining breastfeeding support interventions for healthy breastfeeding mothers with healthy term babies. Click here for access to the audio recording for this webinar: https://youtu.be/fxDY-Q87xaY
Alison McFadden, Senior Research Fellow, Director, Mother and Infant Research Unit, School of Nursing and Health Sciences, University of Dundee and Anna Gavine, Research Fellow School of Nursing and Health Sciences, University of Dundee will be leading the session and presenting findings from their recent Cochrane review:
McFadden A, Gavine A, Renfrew M, Wade A, Buchanan P, Taylor J, et al. (2017). Support for healthy breastfeeding mothers with healthy term babies . Cochrane Database of Systematic Reviews, 2017(2), CD001141.
Evidence suggests that not breastfeeding negatively impacts the health of both infants and mothers. Additionally, data demonstrates an inadequate uptake of the World Health Organization’s recommendations regarding type and duration of breastfeeding in many countries. This review examines the impact of breastfeeding support interventions on breastfeeding duration and exclusivity in healthy breastfeeding mothers with healthy term babies, compared to usual care. One-hundred trials with over 83,246 mother-infant pairs were included in this review. Seventy-three of the one-hundred trials were involved in the data analyses. Findings suggest that breastfeeding support interventions reduce cessation of ‘any breastfeeding’ before 4 to 6 weeks and 6 months, and cessation of ‘exclusive breastfeeding’ at 4 to 6 weeks and at 6 months. This webinar will provide an overview of the impact of support on breastfeeding duration and exclusivity in healthy breastfeeding mothers with healthy term babies.
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
Support for healthy breastfeeding mothers with healthy term babies: What's the evidence?
1. Welcome!
Support for healthy
breastfeeding mothers with
healthy term babies: What's
the evidence?
You will be placed on hold until the webinar begins.
The webinar will begin shortly, please remain on the line.
2. Poll Questions: Consent
• Participation in the webinar poll questions is voluntary
• Names are not recorded and persons will not be identified in any way
• Participation in the anonymous polling questions is accepted as an
indication of your consent to participate
Benefits:
• Results inform improvement of the current and future webinars
• Enable engagement; stimulate discussion. This session is intended for
professional development. Some data may be used for program evaluation
and research purposes (e.g., exploring opinion change)
• Results may also be used to inform the production of systematic reviews
and overviews
Risks: None beyond day-to-day living
3. After Today
• The PowerPoint presentation and audio
recording will be made available
• These resources are available at:
– PowerPoint: http://
www.slideshare.net/HealthEvidence
– Audio Recording:
https://www.youtube.com/user/healthevidence/vide
3
4. What’s the evidence?
McFadden A, Gavine A, Renfrew M, Wade A,
Buchanan P, Taylor J, et al. (2017). Support for
healthy breastfeeding mothers with healthy term
babies. Cochrane Database of Systematic
Reviews, 2017(2), CD001141.
http://www.healthevidence.org/view-
article.aspx?a=support-healthy-
breastfeeding-mothers-healthy-term-babies-
30167
5. • Use CHAT to post comments /
questions during the webinar
– ‘Send’ questions to All (not
privately to ‘Host’)
• Connection issues
– Recommend using a wired
Internet connection (vs.
wireless)
• WebEx 24/7 help line
– 1-866-229-3239
Participant Side Panel in WebEx
Housekeeping
6. Housekeeping (cont’d)
• Audio
– Listen through your speakers
– Go to ‘Communicate > Audio Broadcast’
• WebEx 24/7 help line
– 1-866-229-3239
7. Poll Question #1
How many people are watching today’s
session with you?
A.Just me
B.2-3
C.4-5
D.6-10
E.>10
8. The Health Evidence™ Team
Maureen Dobbins
Scientific Director
Heather Husson
Manager
Susannah Watson
Project Coordinator
Students:
Emily Belita
(PhD candidate)
Jennifer Yost
Assistant Professor
Olivia Marquez
Research Coordinator
Emily Sully
Research Assistant
Liz Kamler
Research Assistant
Zhi (Vivian) Chen
Research Assistant
Research Assistants:
Claire Howarth
Rawan Farran
Kristin Read
Research Coordinator
10. Why use www.healthevidence.org?
1. Saves you time
2. Relevant & current evidence
3. Transparent process
4. Supports for EIDM available
5. Easy to use
11. A Model for Evidence-
Informed Decision Making
National Collaborating Centre for Methods and Tools. (revised 2012). A
Model for Evidence-Informed Decision-Making in Public Health (Fact
Sheet). [http://www.nccmt.ca/pubs/FactSheet_EIDM_EN_WEB.pdf]
12. Stages in the process of Evidence-
Informed Public Health
National Collaborating Centre for Methods and Tools. Evidence-Informed
Public Health. [http://www.nccmt.ca/eiph/index-eng.html]
15. How often do you use Systematic Reviews
to inform a program/services?
A.Always
B.Often
C.Sometimes
D.Never
E.I don’t know what a systematic review is
Poll Question #3
16. Alison McFadden, Senior Research
Fellow, Director, Mother and Infant
Research Unit, School of Nursing and
Health Sciences, University of Dundee
Anna Gavine, Research Fellow,
School of Nursing and Health
Sciences, University of Dundee
17. Why breastfeeding matters
• Impact on children’s and women’s health
• For children: not breastfeeding
mortality/hospitalisation due to preventable
disease
rates of childhood diabetes, obesity, dental
disease
has adverse impact on IQ, educational and
behavioural outcomes
18. Why breastfeeding matters
• For women: not breastfeeding
– Associated with increased risk of breast and
ovarian cancer, and diabetes
– Lactational amenorrhoea increases birth
spacing in contexts where other contraceptive
options are not available
19. Breastfeeding
recommendations
The World Health Organization
recommends that:
•infants should be breastfed exclusively until 6
months of age
•with breastfeeding continuing as an important part
of the infant’s diet until at least two years of age.
20. Breastfeeding Rates
High income countries
In some countries -
marked decline in
breastfeeding after first
few weeks
Low rates of exclusivity
up to 6 months and
continuation beyond 12
months
• Low and middle
income countries
Generally higher rates
of breastfeeding
duration than in HICS
Variable rates of
exclusive
breastfeeding for 6
months
World average 37%
21. Breastfeeding Support
Why is it needed?
•Multi-faceted barriers to breastfeeding
– Societal
– Health system
– Individual
22. Breastfeeding Support
Support - complex intervention to address multi-faceted
barriers to breastfeeding
Information/education – e.g. to dispel myths
Skills to manage breastfeeding – positioning and
attachment, solving problems
Confidence and esteem-building
Practical support – help with other tasks
Social support – creating supportive networks
23. Breastfeeding Support
• By different people: health professionals/lay people
• In different settings: hospital or community
• To groups of women or one-to-one,
• Including family members (typically fathers or
grandmothers) and wider communities
• Offered proactively or reactively
• Provided face-to-face, by telephone or through social
media
• Involving only one contact or regular, ongoing contact
over several months
24. Breastfeeding Support
• Often poor and inconsistent
• Lack of recognition of policy makers and
service commissioners of importance of
breastfeeding
• Lack of investment
• In many health settings, health
practitioners lack in-depth knowledge and
skills
25. Global policy context
• UNICEF/WHO updating Baby-friendly
hospital initiative guidance 2017
– Guidelines on patient care (Ten Steps to
Successful Breastfeeding)
– Implementation guidance for national
programmes (BFHI)
• Update involves 21 systematic reviews on
the Ten Steps
26. Objectives
1. To describe forms of breastfeeding support which have been
evaluated in controlled studies, the timing of the interventions and the
settings in which they have been used.
2. To examine the effectiveness of different modes of offering
similar supportive interventions (for example, whether the support
offered was proactive or reactive, face-to-face or over the telephone), and
whether interventions containing both antenatal and postnatal
elements were more effective than those taking place in the postnatal
period alone.
3. To examine the effectiveness of different care providers and
(where information was available) training.
4. To explore the interaction between background breastfeeding
rates and effectiveness of support.
27. Cochrane Systematic
Reviews
• A systematic review is a review of a clearly formulated question that
uses systematic and explicit methods to identify, select, and critically
appraise relevant research, and to collect and analyze data from the
studies that are included in the review. Statistical methods (meta-
analysis) may or may not be used to analyze and summarize the results
of the included studies. Meta-analysis refers to the use of statistical
techniques in a systematic review to integrate the results of included
studies (Cochrane Collaboration, Cochrane.org)
By Cochrane Collaboration (en:File:Cclogo.svg) [Public
domain], via Wikimedia Commons
28. Methods: Inclusion Criteria
• Study design:
• Randomised or quasi-randomised trials including cluster-
randomised trials.
• Types of participants:
• Healthy pregnant women considering/intending breastfeed or
healthy women breastfeeding healthy babies
• Types of interventions:
• Support supplementary to standard care;
• Offered by health professionals or lay people;
• May or may not include training;
• Group care or individual;
• In hospital, in the community or remotely;
• Proactive or reactive
• Antenatal and postnatal or postnatal only
29. Primary Outcomes
• Stopping any breastfeeding before 4-6 weeks
• Stopping any breastfeeding before 6 months
• Stopping exclusive breastfeeding before 4-6 weeks
• Stopping exclusive breastfeeding before 6 months
30. Methods: Search Strategy and
Study Selection
• Cochrane Pregnancy and Childbirth Group’s Trial
register was searched for trials published between
October 2011 and February 2016.
• No limits on language
• Two review authors independently screened the
reports (n=162).
31. Data Extraction
• Data on study design, participants, setting, characteristics of the intervention,
outcomes was extracted.
• Independently checked by a second reviewer
32. Assessment of Risk of Bias
• Risk of bias assessed using the Higgins Risk of Bias
tool (2011) which looks at following domains:
• Random sequence generation
• Allocation concealment
• Blinding of participants and personnel
• Blinding of outcome assessment
• Incomplete outcome data
• Selective Reporting
• Other bias…
33. GRADE
• Assessment of quality of the evidence. Looks at:
• Type of evidence
• Risk of bias
• The consistency of the effect between or within
studies
• Generalisability of the populations and outcomes
• Effect size
34. Results of the Search
Assessed 163 reports
Included a further 31 studies
Full review now consists of 100 studies involving
more than 83,246 mother-infant pairs
73 studies contribute data
58 individually-randomised trials
15 cluster-randomised trials
36. Characteristics of Included
Studies: Participants
Socio-economic and health status
•Women from general healthy populations
•28 studies of women form low-income groups
Background rates of breastfeeding initiation
Inverse relationship between country income status and
breastfeeding rates
All studies with initiation rates <80% were in HICS
All studies from LICS hade initiation rates >80%
37. Characteristics of Included
Studies: Intervention
• Level of intervention
– women (64)
– education of health care practitioners (8)
– policy (1)
• Characteristics of interventions
– proactive (63)/ reactive (8)
– one-to one (58)/ group (2)/ both (1)/ couples (1)
– professional (49)/ lay (15/ both (9)
– trained (50)
– face-to-face (38)/ telephone (4)/ both (30)
38. Characteristics of Included
Studies: Intervention
• Characteristics of interventions
– postnatal only (49)/ antenatal +postnatal (25)
• Intensity
– ≤3 contacts (24)/ 4-8 contacts (21)/ ≥9 (17)
Control group care
BFHI accredited settings (6)
Remainder ‘standard care’/ not described
39. Risk of Bias in Included
Studies
McFadden et al. (2017). Figure 1. Risk of bias graph: review authors'
judgements about each risk of bias item presented as percentages across all
included studies.
40. Effect of Interventions: Stopping
any breastfeeding at 4-6 weeks
• Measured by a total of 33 studies including 10,776
women
• 31.3% of women intervention vs 34.8% of women in
the control groups stopped any breastfeeding by 6
weeks.
• Relative Risk: 0.87, 95% CI 0.80-0.95
• GRADE: Moderate quality
41. Effect of Interventions: Stopping any
breastfeeding up to six months
• Measured by a total of 40 studies including 14,227
women
• 52.9% of women intervention vs 56.64% of women in
the control groups stopped any breastfeeding by 6
months.
• Relative Risk: 0.91, 95% CI 0.88-0.95
• GRADE: Moderate quality
42. Effect of Interventions: Stopping
exclusive breastfeeding at 4-6 weeks
• Measured by a total of 32 studies including 10,960
women
• 57.2% of women intervention vs 65.0% of women in
the control groups stopped exclusive breastfeeding by
6 weeks.
• Relative Risk: 0.79, 95% CI 0.71-0.81
• GRADE: Moderate quality
43. Effect of Interventions: Stopping
exclusive breastfeeding up to six months
•Measured by a total of 46 studies including 18,591
women
•74.9% of women intervention vs 83.4% of women
in the control groups stopped exclusive
breastfeeding by 6 months.
•Relative Risk: 0.88, 95% CI 0.85-0.92
•GRADE: Moderate quality
44. Subgroup Analysis: Who
delivered the support
•Majority of studies the intervention was delivered by
professionals
•For cessation of exclusive breastfeeding up to 6 months,
greater treatment effects were associated with
interventions delivered by non-professionals
•For cessation of any breastfeeding up to 6 months and
exclusive breastfeeding at 6 weeks there was a possible
treatment effect
•For cessation of any breastfeeding at 4-6 weeks there
was no evidence of any difference
45. Subgroup Analysis: Type of
Support
•Compared face-to-face, with telephone and
telephone + face-to-face
•For cessation of exclusive breastfeeding at 6 weeks
and 6 months there was some evidence in favour of
interventions delivered face-to-face
•For cessation of any breastfeeding at 6 weeks and 6
months there was no evidence to favour a particular
type of support
46. Subgroup Analysis: When the
support was offered
•Compared postnatal only with antenatal +postnatal
•No differences in effect size for any outcome
47. Subgroup Analysis: Proactive
vs Reactive
•All studies included at least 1 proactive contact so
sub-group analysis not appropriate
48. Subgroup Analysis: Background
Breastfeeding Initiation Rates
•Compared high background rates (>80%) with
intermediate rates (60-80%) with low (<60%).
•For cessation of exclusive breastfeeding at 6 weeks
and 6 months, the intervention effect was greater in
areas with high background rates
•For cessation of any breastfeeding at 6 weeks and 6
months there was no evidence of a difference in
intervention effect
49. Subgroup Analysis: Intensity
of Intervention
•Compared < 4 contacts; 4-8 contacts; >8 contacts;
and unspecified number of contacts
•For cessation of exclusive breastfeeding at 6 weeks
and 6 months, the intervention effect was greatest for
women receiving 4-8 contacts
•For cessation of any breastfeeding at 6 weeks and 6
months there was no evidence of a difference in
intervention effect
50. Strengths and Limitations
• Large number of trials and participants across all country
income settings
• Rigorous review methods to minimise bias in the review
process
• Reporting of studies not always clear
• Possible publication bias
• Very diverse interventions
• Wide variation in study endpoints
• Overall risk of bias in studies mixed
51. Implications for Practice
• When breastfeeding support is offered to women, the
duration and exclusivity of breastfeeding is increased
• Characteristics of effective support
– offered as standard by trained personnel during antenatal or
postnatal care
– includes ongoing scheduled visits so that women can predict
when support will be available,
– tailored to the setting and the needs of the population group
– offered by professional or lay/peer supporters, or a combination
of both
– strategies that rely mainly on face-to-face support are more likely
to succeed with women breastfeeding exclusively
52. Implications for Research
• Large number of trials
• Future research could focus on identifying how
such support can best be provided consistently,
for all women, in all countries
– scaling-up
– implementation and quality improvement
approaches
53. Implications for Research
Further research needed on:
•training programmes (which should be well-defined and
reproducible)
•develop the theoretical basis for
•analyse elements have impact
– training, timing, intensity
– differential impact on different population subgroups
•establish the cost-effectiveness of different interventions;
•investigate strategies for supporting women who wish to
breastfeed for longer than six months;
54. Poll Question #4
The information presented today was
helpful
A.Strongly agree
B.Agree
C.Neutral
D.Disagree
E.Strongly disagree
55. What can I do now?
Visit the website; a repository of over 5,000+ quality-rated systematic reviews
related to the effectiveness of public health interventions. Health Evidence™ is
FREE to use.
Register to receive monthly tailored registry updates AND monthly newsletter to
keep you up to date on upcoming events and public health news.
Tell your colleagues about Health Evidence™: helping you use best evidence to
inform public health practice, program planning, and policy decisions!
Follow us @HealthEvidence on Twitter and receive daily public health review-
related Tweets, receive information about our monthly webinars, as well as
announcements and events relevant to public health.
Encourage your organization to use Health Evidence™ to search for and apply
quality-rated review level evidence to inform program planning and policy decisions.
Contact us to suggest topics or provide feedback.
info@healthevidence.org
56. Poll Question #5
What are your next steps? [Check all
that apply]
A.Access the full text systematic review
B.Access the quality assessment for the
review on www.healthevidence.org
C.Consider using the evidence
D.Tell a colleague about the evidence
here’s a look at the team
many involved in the work to keep HE current and maintained
Health Evidence launched in 2005
comprehensive registry of reviews evaluating the effectiveness of public health and health promotion interventions
provide over 90,000 visitors per year access to over 4,600 quality-rated systematic reviews
links to full text, plain language summaries, and podcasts (where available)
One of main goals of Health Evidence, in addition to making evidence re: effectiveness of PH interventions more accessible, is to make it easier for professionals to use evidence in decision making
Model for Evidence-Informed decision making in PH consists of 5 components visible in this diagram
Traditionally public health practitioners and decision makers do consider evidence about community health issues and local context, existing resources, and community and political climate in making decisions about programs and policies however, it has become apparent that a considering evidence about research may be more challenging
As such the Health Evidence webinar series is designed to identify research evidence relevant to public health decisions
The EIPH wheel illustrates the steps involved in evidence-informed practice
The wheel is a guide for practitioners and decision makers to determine how to address a particular issue by systematically incorporating research evidence in the decision making process
There are 7 steps in the EIPH process that starts with:
Clearly defining the problem;
Searching the research literature;
Appraising the evidence you find;
Synthesizing or summarizing the research on your issue;
Adapting and interpreting the findings to your local context;
Implementing the evidence or appropriate intervention; and
Evaluating your implementation efforts.
We will hear today about how (presenter) has worked through the first 4 steps, in order to help with the decision makers with the remainder of the 7 steps
Poll question #4
Breastfeeding has a fundamental impact on the short-, medium- and long-term health of children and has an
important impact on women’s health (Victora 2016). For children, good quality evidence demonstrates that in both low-,
middle- and high-income settings not breastfeeding contributes to mortality due to infectious diseases (Sankar 2015),
hospitalisation for preventable disease such as gastroenteritis, and respiratory disease (Horta 2013), otitis media (Bowatte
2015), increased rates of childhood diabetes and obesity (Horta 2015a), and increased dental disease (Peres 2015; Tham
2015). For women, there is good quality evidence that not breastfeeding is associated with increased risks of
breast and ovarian cancer, and diabetes (Chowdhury 2015). Lactational amenorrhoea is associated with
exclusive/predominant breastfeeding and increases birth spacing when other forms of contraception are not
available (Chowdhury 2015). Not being breastfed has an adverse impact on intelligence quotient (IQ), and
educational and behavioural outcomes for the child (Heikkilä 2014; Heikkilä 2011; Horta 2015b; Quigley 2012). For
many outcomes a dose-response relationship exists, with the greatest benefit resulting from breastfeeding
exclusively, with no added food or fluids, for around six months, with breastfeeding continuing thereafter as an
important component of the infant’s diet (Kramer 2012). The negative impact of not breastfeeding has been
demonstrated in a range of settings and population groups, though the balance of risks and benefits varies from setting
to setting; for example, gastroenteritis will result in much higher mortality in low-income countries (Horta 2013).
Cochrane collaboration founded in 1993. Have now published &gt;6000 systematic reviews many of which have informed national and international health policy.
Healthy women and babies were considered those who did not require additional medical care (e.g. women with diabetes, women with HIV/AIDs, overweight or obese women) or surgical care (e.g. women who required a Caesarean Section). Studies which focused specifically on women with additional care needs were excluded.
Very broad inclusion criteria in terms of intervention. We included any form of support to women that was supplementary to standard. Support included things such as praise, information and the opportunity for mothers to ask questions. It could also include training staff to improve supportive care given.
Support could either be offered by healthcare professionals (eg midwives, obstetricians, lactation consultants) or lay people including peers
We included interventions that provided one-to-one care or group care.
Interventions could be delivered in hospital, primary care settings or other community locations or in the women’s home. We also included interventions where the support was delivered over the phone.
Interventions could be proactive and by that we mean the person providing the intervention contacted the women. By reactive we mean that the women asked for support.
The women did have to be breastfeeding in order to receive the support so we included interventions that were provided in the postnatal period. They could also have an antenatal component. However interventions delivered only in the antenatal period were excluded.
Previous versions of the review did include stopping any or exclusive breastfeeding at other time points (two, three, four, nine and 12 months), measures of neonatal or infant morbidity, measures of maternal satisfaction of care. We had to complete this review in a very short period so we focused on these primary outcomes. A new set of core outcomes for Cochrane pregnancy and childbirth breastfeeding reviews is currently being developed and hopefully by the time we update this review we will be able to use them.
Unlike other systematic reviews where you need to develop your own search strategy and search databases, CPG has created a database of all available reports of controlled trials related to pregnancy and childbirth. They do this through searching databases such as medline, cinahl and handsearching journals and conference proceedings. Two members of the CPG then allocate each report to a topic area. The list of all reports the topic area relevant to the review is then provided to review authors.
As this review last updated in October 2011 we examined all reports published between then and Febuary 2016.
162 trials were categorised as related to lactation so we retrieved these and these were independently screened by 2 review authors. Any disagreements were resolved by discussing with a 3rd author.
We did not have any restrictions on language and when non English papers were identified the CPG organised translation for us.
First done using a data extraction form that we developed.
Main challenge here was getting data into a format that we could use for the meta-analysis. What we need is just the raw data. However, often authors do not provide this so you need to work backwards from the statistics provided in the paper or contact the study author for more information.
Then entered into revman
This is the standard tool for assessing risk of bias in controlled trials. Each trial was assessed independently by 2 reviwers,
Random sequence generation. Was this truly random (eg computer random number generator) or was the sequence generated by non random means (e.g. odd or even date of birth)
Allocation concealment. We were looking at whether allocation could have been forseen and therefore manipulated in anyway. So looking for things like centralised randomisation procedure or the use of consecutive sealed envelopes to be classed as low ROB
Blinding of participants and personnel. This refers to whether participants and staff providing the intervention or other healthcare providers knew whether they were receiving the intervention.
Blinding of outcome assessment. Whether the staff collecting the outcome data knew which group the participant had been assigned to.
Incomplete Outcome data. This looks at how many participants dropped out and if this varied between groups. As a rule of thumb we considered attrition of &gt;25% high ROB
Selective Reporting. This involved checking that the study authors reported all the outcomes they said they would and were not omitting results. The main way we checked against this was comparison with the study protocol when available.
Other bias included things like baseline imbalance, issues to do with clustering or contamination of the intervention
Finally the quality of the evidence was assessed using GRADE. was developed by the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) Working Group to help make a systematic and explicit approach to making judgements about the strength of the evidence.
This looks at things like the study design, risk of bias, amount of variation of the study effect sizes, generalisability of the studies and the effect size. Taking all this information into account an overall score of high, moderate, low or very low quality is made
Studies conducted in 27 countries
4 LIC (Bangladesh, Burkina Faso, Uganda, Democratic Republic of the Congo)
4 LMIC (India, Kenya, Pakistan, Kenya)
8 UMIC (Belarus, Brazil, China, Iran, Malaysia, Mexico, Turkey, South Africa)
11 HIC (mainly UK and US) Australia, Canada, Denmark, Croatia, France, Hong Kong, Italy, Netherlands. Singapore, Sweden, UK (8), US (20)
Lack of blinding or information about blinding of participants and personnel and outcome assessment was a big issue. Due to the nature of the intervention it was often not possible to blind women or staff providing the intervention. Also in the majority of studies data was collected in the form of self report so as the women were aware of intervention status the outcome assessors were not blinded.
Another common issue was lack of a research protocol published before the study took place. This meant we were unable to compare the reported outcomes with the outcomes that were planned.
This was a significant difference between the groups with women not receiving support being 13% less likely to be doing any breastfeeding at 6 weeks.
When we took out the studies at risk of bias for allocation concealment the difference was still significance although the effect size very slightly reduced to 0.88
The quality was downgraded to moderate because of statistical heterogeneity suggesting varience in effect estimates. We didn’t downgrade because of risk of bias in any outcome because the sensitivity analysis was robust
This was a significant difference between the groups with women not receiving support being 9% less likely to be doing any breastfeeding at 6 months
When we took out the studies at risk of bias for allocation concealment the difference was still significance although again the effect size rediced to 0.93.
Quality was downgraded because of statistical heterogeneity suggesting varience in effect estimates
This outcome demonstrated the largest effect sizes.
This was a significant difference between the groups with women not receiving support being 21% less likely to be exclusive breastfeeding at 6 weeks
When we took out the studies at risk of bias for allocation concealment the difference was still significance although the effect size rediced to 0.8 in the studies at low rob.
The study was downgraded to moderate quality because of statistical heterogeneity suggesting varience in effect estimates
This was a significant difference between the groups with women not receiving support being 12% less likely to be exclusive breastfeeding at 6 months
When we took out the studies at risk of bias for allocation concealment the difference was still significance although again the effect size rediced to 0.93 in the studies at low ROB
The study was downgraded to moderate quality because of statistical heterogeneity suggesting varience in effect estimates
The imbalance in sub-groups makes comparisons difficult.
What we can say is that for exclusive breastfeeding at 6 months there was a statistical difference which supported interventions delivered by lay people.
For cessation of any breastfeeding up to 6 months and exclusive breastfeeding at 6 weeks there was suggestion that larger intervention effects were associated with studies delivered by lay people. However we are not confident in these results as the number of trials with interventions delivered by lay people is much smaller than those delivered by professionals.
Advise caution in interpreting results due to high levels of statistical heterogeneity (ie variance within the groups)
This was a planned analysis that we did not undertake.
the four studies from low-/low-middle income countries had the highest rates and All the studies with intermediate or low background rates of breastfeeding initiation were undertaken in high-income countries.
The intervention effect was strongest for Exclusive breastfeeding at 6 weeks and 6 months in studies with initation rates showing the importance of interventions that also promote breastfeeding initation.
There was no difference in intervention effect for any breastfeeding at 6 weeks or 6 months according to background initiation rates.
Again we do advise caution in interpreting this result. Differences in the sub groups could also be explained by differences in risk of bias between studies with the studies with more pronounced treatment effects at greater risk of bias. There was also differences in the settings of visits with the studies offering more visits tending to be carried out face to face which may confound the results
Reporting deficits - description of the components of the support intervention, details of the training and qualifications of the supporters,
the definitions used of the extent of breastfeeding and in the description of adherence to the support protocol. failure to present details of the interventions and of the standard care available to both intervention and comparison groups. Very few of the trials described a theoretical basis for the intervention tested, with the result that the findings are difficult to explain or to replicate.
Publication bias: Smaller studies showing a less beneficial effect of the intervention may be missing.
This should be a check-box answer (i.e. select all that apply)